A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies (Q82847250)
Jump to navigation
Jump to search
scientific article published on 09 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies |
scientific article published on 09 February 2010 |
Statements
A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies (English)
Roy S Herbst
D Ross Camidge
Michael S Gordon
S Gail Eckhardt
Blythe Durbin
Josephine Ing
Tanyifor M Tohnya
Jason Sager
Avi Ashkenazi
Gordon Bray
David Mendelson
9 February 2010